Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Serum uric acid level in primary hypertension among Chinese nonagenarians/centenarians

Abstract

Epidemiologic studies suggest an independent positive association of elevated serum uric acid with essential hypertension. However, to date, limited information is available in the old population. In the present study, we included 832 unrelated Chinese nonagenarians/centenarians (269 men and 563 women; ranged in age from 90 to 108 years (mean, 94.6±4.0)). The mean serum uric acid level was 320 μmol l−1 (standard deviation 87 μmol l−1). After adjustment for age, body mass index, waist-to-hip ratio, smoking habits, tea habits, alcohol consumption, fasting plasma glucose, plasma lipids and serum creatinine, the odds ratio comparing the highest with lowest quartile of serum uric acid were 0.67 (95% confidence interval (CI), 0.33–1.21) and 1.36 (95% CI, 0.88–2.22) in men and women, respectively. When compared with normotensive subjects, we did not observe statistical higher serum uric acid levels in subjects with hypertension. In summary, we found that serum uric acid level is not directly correlated with hypertension among Chinese nonagenarians/centenarians.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P . The burden of adult hypertension in the United States 1999–2000—a rising tide. Hypertension 2004; 44: 398–404.

    Article  CAS  Google Scholar 

  2. Mahomed FA . On chronic Bright's disease, and its essential symptoms. Lancet 1879; I: 399–401.

    Article  Google Scholar 

  3. Dollery CT, Duncan H, Schumer B . Hyperuricaemia related to treatment of hypertension. BMJ 1960; 2: 832–835.

    Article  CAS  Google Scholar 

  4. Breckenridge A . Hypertension and hyperuricaemia. Lancet 1966; 1: 15–18.

    Article  CAS  Google Scholar 

  5. Cannon PJ, Stason WB, Demartini FE, Sommers SC, Laragh JH . Hyperuricemia in primary and renal hypertension. N Engl J Med 1966; 275: 457–464.

    Article  CAS  Google Scholar 

  6. Kahn HA, Medalie JH, Neufeld HN, Riss E, Goldbourt U . The incidence of hypertension and associated factors: the Israel ischemic heart disease study. Am Heart J 1972; 84: 171–182.

    Article  CAS  Google Scholar 

  7. Selby JV, Friedman GD, Quesenberry CPJ . Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 1990; 131: 1017–1027.

    Article  CAS  Google Scholar 

  8. Hunt SC, Stephenson SH, Hopkins PN, Williams RR . Predictors of an increased risk of future hypertension in Utah. A screening analysis. Hypertension 1991; 17: 969–976.

    Article  CAS  Google Scholar 

  9. Jossa F, Farinaro E, Panico S, Krogh V, Celentano E, Galasso R et al. Serum uric acid and hypertension: the Olivetti heart study. J Hum Hypertens 1994; 8: 677–681.

    CAS  PubMed  Google Scholar 

  10. Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K . Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: the Osaka Health Survey. J Hypertens 2001; 19: 1209–1215.

    Article  CAS  Google Scholar 

  11. Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML . Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003; 42: 474–480.

    Article  CAS  Google Scholar 

  12. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K . Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol 2003; 18: 523–530.

    Article  CAS  Google Scholar 

  13. Nagahama K, Inoue T, Iseki K, Touma T, Kinjo K, Ohya Y et al. Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan. Hypertens Res 2004; 27: 835–841.

    Article  Google Scholar 

  14. Alper Jr AB, Chen W, Yau L, Srinivasan SR, Berenson GS, Hamm LL . Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension 2005; 45: 34–38.

    Article  CAS  Google Scholar 

  15. Sundstrom J, Sullivan L, D'Agostino RB, Levy D, Kannel WB, Vasan RS . Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005; 45: 28–33.

    Article  Google Scholar 

  16. Shankar A, Klein R, Klein BE, Nieto FJ . The association between serum uric acid level and long-term incidence of hypertension: population-based cohort study. J Hum Hypertens 2006; 20: 937–945.

    Article  CAS  Google Scholar 

  17. Mellen PB, Bleyer AJ, Erlinger TP, Evans GW, Nieto FJ, Wagenknecht LE et al. Serum uric acid predicts incident hypertension in a Biethnic Cohort: the Atherosclerosis Risk in Communities Study. Hypertension 2006; 48: 1037–1042.

    Article  CAS  Google Scholar 

  18. Krishnan E, Kwoh CK, Schumacher HR, Kuller L . Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 2007; 49: 298–303.

    Article  CAS  Google Scholar 

  19. Feig DI, Johnson RJ . Hyperuricemia in childhood primary hypertension. Hypertension 2003; 42: 247–252.

    Article  CAS  Google Scholar 

  20. Forman JP, Choi H, Curhan GC . Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol 2007; 18: 287–292.

    Article  CAS  Google Scholar 

  21. Dang A, Zhang Y, Liu G, Chen G, Song W, Wang B . Effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia in Chinese population. J Hum Hypertens 2006; 20: 45–50.

    Article  CAS  Google Scholar 

  22. Rayner BL, Trinder YA, Baines D, Isaacs S, Opie LH . Effect of losartan versus candesartan on uric acid, renal function, and fibrinogen in patients with hypertension and hyperuricemia associated with diuretics. Am J Hypertens 2006; 19: 208–213.

    Article  CAS  Google Scholar 

  23. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42: 1206–1252.

    Article  CAS  Google Scholar 

  24. Alberti KG, Zimmet P, Shaw J . Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469–480.

    Article  CAS  Google Scholar 

  25. Domagk GF, Schlicke HH . A colorimetric method using uricase and peroxidase for the determination of uric acid. Anal Biochem 1968; 22: 219–224.

    Article  CAS  Google Scholar 

  26. Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, Sari I et al. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens 2006; 19: 1055–1062.

    Article  CAS  Google Scholar 

  27. Rho YH, Woo JH, Choi SJ, Lee YH, Ji JD, Song GG . Association between serum uric acid and the Adult Treatment Panel III-defined metabolic syndrome: results from a single hospital database. Metabolism 2008; 57: 71–76.

    Article  CAS  Google Scholar 

  28. Ford ES, Li C, Cook S, Choi HK . Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007; 115: 2526–2532.

    Article  CAS  Google Scholar 

  29. Maxwell AJ, Bruinsma KA . Uric acid is closely linked to vascular nitric oxide activity: evidence for mechanism of association with cardiovascular disease. J Am Coll Cardiol 2001; 38: 1850–1858.

    Article  CAS  Google Scholar 

  30. Jaramillo M, Naccache PH, Olivier M . Monosodium urate crystals synergize with IFN-{gamma} to generate macrophage nitric oxide: involvement of extracellular signal-regulated kinase 1/2 and NF-{kappa}B. J Immunol 2004; 172: 5734–5742.

    Article  CAS  Google Scholar 

  31. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002; 13: 2888–2897.

    Article  CAS  Google Scholar 

  32. Kang DH, Park SK, Lee IK, Johnson RJ . Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005; 16: 3553–3562.

    Article  CAS  Google Scholar 

  33. Watanabe S, Kang D-H, Feng L, Nakagawa T, Kanellis J, Lan H et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension 2002; 40: 355–360.

    Article  CAS  Google Scholar 

  34. Kang DH, Han L, Ouyang X, Kahn AM, Kanellis J, Li P et al. Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol 2005; 25: 425–433.

    Article  CAS  Google Scholar 

  35. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006; 290: F625–F631.

    Article  CAS  Google Scholar 

  36. Johnson RJ, Kang D-H, Feig D, Kivlighn S, Kanellis J, Watanabe S et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183–1190.

    Article  CAS  Google Scholar 

  37. Ruggiero C, Cherubini A, Ble A, Bos AJG, Maggio M, Dixit VD et al. Uric acid and inflammatory markers. Eur Heart J 2006; 27: 1174–1181.

    Article  CAS  Google Scholar 

  38. Sanchez-Lozada LG, Nakagawa T, Kang DH, Feig DI, Franco M, Johnson RJ et al. Hormonal and cytokine effects of uric acid. Curr Opin Nephrol Hypertens 2006; 15: 30–33.

    Article  CAS  Google Scholar 

  39. Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M . Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals. Atherosclerosis 2007; 192: 131–137.

    Article  CAS  Google Scholar 

  40. Wang TJ, Gona P, Larson MG, Levy D, Benjamin EJ, Tofler GH et al. Multiple biomarkers and the risk of incident hypertension. Hypertension 2007; 49: 432–438.

    Article  CAS  Google Scholar 

  41. Mazzali M, Kanellis J, Han L, Feng L, Xia Y-Y, Chen Q et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002; 282: F991–F997.

    Article  CAS  Google Scholar 

  42. Fuiano G, Sund S, Mazza G, Rosa M, Caglioti A, Gallo G et al. Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects. Kidney Int 2001; 59: 1052–1058.

    Article  CAS  Google Scholar 

  43. Brand FN, McGee DL, Kannel WB, Stokes III J, Castelli WP . Hyperuricemia as a risk factor of coronary heart disease: the Framingham Study. Am J Epidemiol 1985; 121: 11–18.

    Article  CAS  Google Scholar 

  44. Kannel WB . Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am Heart J 1987; 114: 413–419.

    Article  CAS  Google Scholar 

  45. Casiglia E, Spolaore P, Ginocchio G, Colangeli G, Di Menza G, Marchioro M et al. Predictors of mortality in very old subjects aged 80 years or over. Eur J Epidemiol 1993; 9: 577–586.

    Article  CAS  Google Scholar 

  46. Kaplan NM, Opie LH . Controversies in cardiology 2—controversies in hypertension. Lancet 2006; 367: 168–176.

    Article  Google Scholar 

  47. Ames BN, Cathcart R, Schwiers E, Hochstein P . Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. PNAS 1981; 78: 6858–6862.

    Article  CAS  Google Scholar 

  48. Rosell M, Regnstrom J, Kallner A, Hellenius ML . Serum urate determines antioxidant capacity in middle-aged men—a controlled, randomized diet and exercise intervention study. J Intern Med 1999; 246: 219–226.

    Article  CAS  Google Scholar 

  49. Maxwell SR, Thomason H, Sandler D, Leguen C, Baxter MA, Thorpe GH et al. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1997; 27: 484–490.

    Article  CAS  Google Scholar 

  50. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG . Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis 2000; 148: 131–139.

    Article  CAS  Google Scholar 

  51. Paolisso G, Barbieri M, Bonafe M, Franceschi C . Metabolic age modelling: the lesson from centenarians. Eur J Clin Invest 2000; 30: 888–894.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the project of Science and Technology Bureau of Sichuan Province (2006Z09-006-4), Construction Fund for Subjects of West China Hospital of Sichuan University (XK05001). The authors thank the staff of the Department of Geriatrics Medicine, West China Hospital and Dujiangyan Hospital, and all participants (as well as their legal proxies) for their great contribution. Mr Guangjian Liu and Mr Wei Ji are also acknowledged for their statistics assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B Dong.

Additional information

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lu, Z., Dong, B., Wu, H. et al. Serum uric acid level in primary hypertension among Chinese nonagenarians/centenarians. J Hum Hypertens 23, 113–121 (2009). https://doi.org/10.1038/jhh.2008.104

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2008.104

Keywords

This article is cited by

Search

Quick links